CLINICAL_TRIALS
trial_result
· 2020-08-19
Clinical Trial Update: Clinical Equivalence Study of Mometasone Nasal Spray [Phase 3]
Summary
A Phase 3 clinical trial evaluating equivalence of mometasone nasal spray for seasonal allergic rhinitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actavis Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2020-08-19